BANK VONTOBEL/CALL/ABBVIE/175/0.1/20.09.24 Share Price

Warrant

DE000VM3MEL6

Delayed Deutsche Boerse AG 12:52:36 03/06/2024 BST
0.24 EUR +29.73% Intraday chart for BANK VONTOBEL/CALL/ABBVIE/175/0.1/20.09.24
1 month-53.75%
3 months-84.84%
Date Price Change
03/06/24 0.24 +29.73%
31/05/24 0.185 +22.52%
30/05/24 0.151 +10.22%
29/05/24 0.137 +4.58%
28/05/24 0.131 -23.84%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 12:52 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM3MEL
ISINDE000VM3MEL6
Date issued 06/10/2023
Strike 175 $
Maturity 20/09/2024 (109 Days)
Parity 10 : 1
Emission price 0.4
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.56
Lowest since issue 0.131
Delta0.26x
Omega 16.02
Premium10.16x
Gearing61.65x
Moneyness 0.9214
Difference Strike 12.27 $
Difference Strike %+7.01%
Spread 0.01
Spread %4.07%
Intrinsic value 0.000000

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
161.2 USD
Average target price
182.1 USD
Spread / Average Target
+12.95%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW